Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria.
<h4>Background</h4>Plasmodium vivax occurs as a latent infection of liver and a patent infection of red blood cells. Radical cure requires both blood schizontocidal and hypnozoitocidal chemotherapies. The hypnozoitocidal therapies available are primaquine and tafenoquine, 8-aminoquinolin...
Guardado en:
Autores principales: | Ari Winasti Satyagraha, Arkasha Sadhewa, Lydia Visita Panggalo, Decy Subekti, Iqbal Elyazar, Saraswati Soebianto, Nunung Mahpud, Alida Rosita Harahap, J Kevin Baird |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/62fae71b29a244dea480166be7d643bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
por: Walter R J Taylor, et al.
Publicado: (2021) -
Genetic Variation of G6PD and CYP2D6: Clinical Implications on the Use of Primaquine for Elimination of Plasmodium vivax
por: Alexandra G. A. Stewart, et al.
Publicado: (2021) -
Dos nuevas mutaciones de glucosa 6 fosfato deshidrogenasa, G6PD Santiago y G6PD Calvo Mackenna
por: Dal Borgo A,Patricia, et al.
Publicado: (2000) -
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
por: Y ZahedPasha, et al.
Publicado: (2006) -
The prevalence of G6PD deficiency in the newborns of Babol, 1995
por: Y ZahedPasha
Publicado: (1999)